Although SARS-CoV-2 severe infection is associated with a hyperinflammatory state,
lymphopenia is an immunological hallmark, and correlates with poor prognosis in COVID …

Background In critically ill COVID-19 patients, the initial response to SARS-CoV-2 infection
is characterized by major immune dysfunctions. The capacity of these severe patients to …

OBJECTIVE: Complete blood count parameters are frequently altered in COVID-19 patients.
Leucopenia and lymphopenia are the most common findings. This is not specific to COVID …

The outbreak of the novel coronavirus disease 2019 (COVID-19) infection began in
December 2019 in Wuhan, and rapidly spread to many provinces in China. The number of …

Abstract Background Coronavirus disease 2019 (COVID-19) is posing a huge threat to
human health worldwide. We aim to investigate the immune status of CD8+ T and NK cells …

Background SARS-CoV-2 has been responsible for considerable mortality worldwide, owing
in particular to pulmonary failures such as ARDS, but also to other visceral failures and …

Introduction: The aim of this study was to evaluate the immune and inflammatory responses
in COVID-19 patients by dosing specific IgM and IgG total antibodies and interleukin 6 …

The cytokine release syndrome has been proposed as the driver of inflammation in
coronavirus disease 2019 (COVID-19). However, studies on longitudinal cytokine profiles in …

In December 2019, cases of severe coronavirus 2019 (COVID-19) infection rapidly
progressed to acute respiratory failure. This study aims to assess the association between …

The role of lymphocytes and their main subsets as prognostic factors of death in SARS-CoV-
2-infected patients remains unclear, with no information obtained from patients outside …